Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dissenting degradation: Deubiquitinases in cell cycle and cancer
Thomas Bonacci, Michael J. Emanuele
Seminars in Cancer Biology (2020) Vol. 67, pp. 145-158
Open Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

The Influence of Cell Cycle Regulation on Chemotherapy
Ying Sun, Yang Liu, Xiaoli Ma, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6923-6923
Open Access | Times Cited: 204
Advances in research on the anti-tumor mechanism of Astragalus polysaccharides
Qian Yang, Dandan Meng, Qinyuan Zhang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 25
Effects and Mechanisms of Luteolin, a Plant-Based Flavonoid, in the Prevention of Cancers via Modulation of Inflammation and Cell Signaling Molecules
Saleh A. Almatroodi, Ahmad Almatroudi, Hajed Obaid Alharbi, et al.
Molecules (2024) Vol. 29, Iss. 5, pp. 1093-1093
Open Access | Times Cited: 17
An insight into the anticancer potentials of lignan arctiin: A comprehensive review of molecular mechanisms
Raihan Chowdhury, Md. Shimul Bhuia, Polrat Wilairatana, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32899-e32899
Open Access | Times Cited: 16
Ubiquitin-Specific Proteases: Players in Cancer Cellular Processes
Lucas Lopes Cruz, Paula Soares, Marcelo Correia
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 848-848
Open Access | Times Cited: 66
Targeting the Ubiquitin–Proteasome System and Recent Advances in Cancer Therapy
Daniela Spano, Giuliana Catara
Cells (2023) Vol. 13, Iss. 1, pp. 29-29
Open Access | Times Cited: 27
USP5 stabilizes YTHDF1 to control cancer immune surveillance through mTORC1-mediated phosphorylation
Na Shao, Lei Xi, Yangfan Lv, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
USP2-Related Cellular Signaling and Consequent Pathophysiological Outcomes
Hiroshi Kitamura, Mayuko Hashimoto
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1209-1209
Open Access | Times Cited: 49
USP36 promotes tumorigenesis and drug sensitivity of glioblastoma by deubiquitinating and stabilizing ALKBH5
Guoqiang Chang, Gloria S. Xie, Li Ma, et al.
Neuro-Oncology (2022) Vol. 25, Iss. 5, pp. 841-853
Open Access | Times Cited: 31
Efficacy of Rotundic Acid and Its Derivatives as Promising Natural Anticancer Triterpenoids: A Literature‐Based Study
Md. Shimul Bhuia, Raihan Chowdhury, Fatema Akter Sonia, et al.
Chemistry & Biodiversity (2023) Vol. 21, Iss. 2
Closed Access | Times Cited: 17
The role of USP7-YY1 interaction in promoting colorectal cancer growth and metastasis
Zhiying Shao, Wendong Yang, Hui Qiu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 7
USP21 regulates Hippo signaling to promote radioresistance by deubiquitinating FOXM1 in cervical cancer
Zhengliang Li, Xiaojing Liu, Haizhou Yu, et al.
Human Cell (2021) Vol. 35, Iss. 1, pp. 333-347
Closed Access | Times Cited: 35
DNA nanostructures for stimuli-responsive drug delivery
Ting Wang, Yanfei Liu, Qing Wu, et al.
Smart Materials in Medicine (2021) Vol. 3, pp. 66-84
Open Access | Times Cited: 35
USP22 upregulates ZEB1-mediated VEGFA transcription in hepatocellular carcinoma
Kai Zeng, Weiwen Xie, Chunyu Wang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 15
AtomNet-Aided OTUD7B Inhibitor Discovery and Validation
Jianfeng Chen, Derek L. Bolhuis, Christian Laggner, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 517-517
Open Access | Times Cited: 14
Discovery and Characterization of BAY-805, a Potent and Selective Inhibitor of Ubiquitin-Specific Protease USP21
Fabian Göricke, Victoria Vu, Leanna Smith, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 5, pp. 3431-3447
Open Access | Times Cited: 14
USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells
Jinqiu Zhao, Jie Bai, Fengling Peng, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 13
Strategies that regulate LSD1 for novel therapeutics
Meng Li, Mengge Dai, Bingchuan Cheng, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 4, pp. 1494-1507
Open Access | Times Cited: 5
Roles of ubiquitin-specific proteases in inflammatory diseases
Rui Chen, Hui Zhang, Linke Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Cinobufotalin regulates the USP36/c-Myc axis to suppress malignant phenotypes of colon cancer cells in vitro and in vivo
Yongjun Hu, Ming Luo
Aging (2024) Vol. 16, Iss. 6, pp. 5526-5544
Open Access | Times Cited: 5
Deubiquitylases in developmental ubiquitin signaling and congenital diseases
Mohammed A. Basar, David B. Beck, Achim Werner
Cell Death and Differentiation (2020) Vol. 28, Iss. 2, pp. 538-556
Open Access | Times Cited: 35
USP15: a review of its implication in immune and inflammatory processes and tumor progression
Anna Georges, Philippe Gros, Nassima Fodil
Genes and Immunity (2021) Vol. 22, Iss. 1, pp. 12-23
Closed Access | Times Cited: 29
EOAI, a ubiquitin-specific peptidase 5 inhibitor, prevents non-small cell lung cancer progression by inducing DNA damage
Yuanyuan Zheng, Longhao Wang, Xiaoyu Niu, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 12
USP7 promotes the osteoclast differentiation of CD14+ human peripheral blood monocytes in osteoporosis via HMGB1 deubiquitination
Yucong Lin, Guan Zheng, Huatao Liu, et al.
Journal of Orthopaedic Translation (2023) Vol. 40, pp. 80-91
Open Access | Times Cited: 12
USP8 promotes gemcitabine resistance of pancreatic cancer via deubiquitinating and stabilizing Nrf2
Jing Cui, Yao Guo, Tao Yin, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115359-115359
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top